Molecular Templates Inc. (MTEM)
OTC: MTEM
· Real-Time Price · USD
0.00
-0.00 (-100.00%)
At close: Apr 02, 2025, 11:52 AM
Molecular Templates Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 572K | 11.09M | 7.02M | 6.8M | 6.63M | 33.63M | 2.61M | 4.24M | 4.42M | 8.49M | 17.96M | 2.38M | 15.13M | 3.22M |
Cost of Revenue | 5.4M | 1.15M | 1.28M | 1.5M | 13.41M | 16.04M | n/a | 21.97M | 1.9M | 1.87M | 1.8M | 22.88M | 21.13M | 21.37M |
Gross Profit | -4.83M | 9.94M | 5.73M | 5.3M | -6.79M | 17.59M | 2.61M | -17.73M | 2.52M | 6.61M | 16.16M | -20.5M | -5.99M | -18.15M |
Operating Income | -8.3M | -50K | -5.37M | 5.14M | -11.74M | 11.79M | -21.06M | -23.67M | -23.84M | -20.63M | -9.3M | -29.53M | -14.91M | -26.33M |
Interest Income | 130K | 109K | 178K | 210K | 365K | 455K | 425K | 307K | 186K | 70K | 126K | 175K | 81K | 52K |
Pretax Income | -8.1M | 572K | -3.96M | 4.15M | -10.87M | 10.85M | -22.02M | -24.61M | -24.75M | -21.61M | -10.24M | -30.39M | -15.6M | -26.78M |
Net Income | -8.1M | 572K | -3.95M | 4.15M | -10.87M | 10.85M | -22.05M | -24.64M | -25.65M | -22.59M | -10.24M | -30.39M | -15.6M | -26.78M |
Selling & General & Admin | 3.47M | 2.58M | 2.31M | 4.31M | 5.2M | 5.8M | 6.08M | 5.93M | 6.57M | 7.62M | 7.93M | 9.03M | 8.92M | 8.18M |
Research & Development | 5.4M | 7.41M | 8.8M | 5.73M | 13.41M | 19.04M | 17.59M | 21.97M | 21.69M | 21.5M | 19.34M | 22.88M | 21.13M | 21.37M |
Other Expenses | -383K | n/a | n/a | 1.89M | 6.79M | -3M | n/a | n/a | 16.95M | 13.01M | 71.53M | 20.5M | 8.23M | 21.13M |
Operating Expenses | 8.48M | 9.98M | 11.11M | 11.93M | 18.37M | 21.84M | 23.67M | 27.91M | 28.26M | 29.12M | 27.27M | 31.91M | 30.05M | 29.55M |
Interest Expense | 38K | 31K | 39K | 31K | 1.19M | 1.4M | 1.39M | 1.25M | 1.09M | 1.05M | 1.07M | 1.03M | 767K | 501K |
Selling & Marketing Expenses | n/a | -1.15M | -1.28M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 8.87M | 11.14M | 12.39M | 11.93M | 18.37M | 21.84M | 23.67M | 27.91M | 28.26M | 29.12M | 27.27M | 31.91M | 30.05M | 29.55M |
Income Tax Expense | n/a | 1.11M | -11K | -1.51M | 1.19M | n/a | 27K | 26K | 906K | 980K | 1.07M | 175K | 81K | -1.46M |
Shares Outstanding (Basic) | 6.56M | 5.37M | 5.37M | 5.09M | 3.76M | 3.76M | 3.76M | 3.76M | 56.33M | 56.31M | 3.67M | 3.74M | 3.71M | 3.5M |
Shares Outstanding (Diluted) | 6.56M | 7.02M | 5.37M | 5.09M | 3.76M | 3.76M | 3.76M | 3.76M | 56.33M | 56.31M | 3.75M | 3.74M | 3.74M | 3.5M |
EPS (Basic) | -1.23 | 0.11 | -0.73 | 0.82 | -2.89 | 2.89 | -5.87 | -6.56 | -0.46 | -0.4 | -2.79 | -8.11 | -4.2 | -7.64 |
EPS (Diluted) | -1.23 | 0.08 | -0.73 | 0.82 | -2.89 | 2.89 | -5.87 | -6.56 | -0.46 | -0.4 | -2.73 | -8.11 | -4.17 | -7.64 |
EBITDA | -7.01M | 1.1M | -2.64M | -2.62M | -7.68M | 14.17M | -18.82M | -21.36M | -21.43M | -18.69M | -7.38M | -27.65M | -13.23M | -24.78M |
EBIT | -8.06M | 603K | -3.92M | -4.12M | -9.68M | 12.24M | -20.63M | -23.39M | -23.33M | -20.56M | -9.18M | -29.35M | -14.83M | -26.28M |
Depreciation & Amortization | 1.08M | 1.15M | 1.28M | 1.5M | 2M | 1.93M | 1.82M | 1.82M | 1.9M | 1.87M | 1.8M | 1.7M | 1.6M | 1.5M |